Financial Enhancement Group’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-55,971
Closed -$413K 132
2024
Q2
$413K Buy
55,971
+1,058
+2% +$9.23K 0.07% 96
2024
Q1
$490K Sell
54,913
-1,431
-3% -$12.5K 0.08% 98
2023
Q4
$473K Buy
+56,344
New +$375K 0.08% 94
2023
Q1
Sell
-139,475
Closed -$933K 126
2022
Q4
$933K Sell
139,475
-112,444
-45% -$1.16M 0.18% 80
2022
Q3
$2.25M Sell
251,919
-1,233
-0.5% -$14.2K 0.52% 44
2022
Q2
$2.62M Sell
253,152
-88,382
-26% -$1.31M 0.57% 41
2022
Q1
$7.12M Buy
341,534
+73,025
+27% +$1.59M 1.32% 21
2021
Q4
$6.87M Sell
268,509
-81,978
-23% -$2.26M 1.21% 25
2021
Q3
$11.1M Sell
350,487
-83,324
-19% -$2.89M 2.09% 13
2021
Q2
$17.4M Buy
433,811
+162,923
+60% +$6.62M 3.56% 7
2021
Q1
$11.5M Buy
+270,888
New +$12.5M 2.34% 12

Other funds holding MSOS

Financial Enhancement Group's MSOS Position: Q3 2024 in Review

Financial Enhancement Group sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q3 2024, closing a stake of 55,971 shares — an estimated $413K sold.

Financial Enhancement Group first reported a position in MSOS in Q1 2021 and held it in 11 quarters. The position peaked at $17.4M in Q2 2021. 170 funds tracked by Wall St. Rank hold MSOS as of Q3 2024.

  • Financial Enhancement Group reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q3 2024 after selling out during the quarter.
  • Financial Enhancement Group sold 55,971 AdvisorShares Pure US Cannabis ETF shares in Q3 2024, an estimated $413K.
  • Financial Enhancement Group first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2021 and held it in 11 quarters.
  • Financial Enhancement Group's AdvisorShares Pure US Cannabis ETF position peaked at $17.4M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2024.

Based on Financial Enhancement Group's 13F filing for Q3 2024, filed 31 Oct 2024.